OnQuality

is a China-based biopharmaceutical company that develops and commercializes medicinal drugs for the treatment of cancer...
Read more
OnQuality President & CEO: Michael McCullar

President & CEO

Michael McCullar

CEO Approval Rating

90/100

Est. Annual Revenue
$100K-5.0M
Agree?
Est. Employees
1-25
Agree?
Funding
$35M

News

Jan 04, 2024
PR Newswire
Press Release: OnQuality : OnQuality Announces FDA Clearance of IND Application for OQL025 for the treatment of EGFR Inhibitor-Induced Acneiform Rash
Jun 07, 2023
StreetInsider
Press Release: OnQuality : OnQuality Announces FDA Clearance of IND Application for OQL051, for the Prophylaxis of Chemotherapy-Induced Diarrhea
May 02, 2023
Pharmabiz
OnQuality: US FDA clears OnQuality's IND application to begin phase 2 trial of OQL036 to treat for capecitabineinduced HFS
Apr 28, 2023
StreetInsider
Press Release: OnQuality : OnQuality Announces FDA Clearance of IND Application for OQL036 for the Prophylaxis of Capecitabine-Induced Hand-Foot Syndrome
Apr 18, 2023
GlobeNewswire
Press Release: OnQuality : Ashvattha Therapeutics Presented Promising Preclinical Data on Novel Macrophage Switching Nanomedicine D-4559 at AACR Annual Meeting
Jan 05, 2023
PR Newswire
Press Release: OnQuality : OnQuality Pharmaceuticals Expands Part 2 of the NOVA-II Phase 2 Clinical Trial to China and India
Oct 14, 2022
Markets Insider
OnQuality: OnQuality Pharmaceuticals to Present Two Posters at the 34th EORTC-NCI-AACR Symposium
May 27, 2022
FirstWord Pharma
OnQuality: OnQuality Pharmaceuticals to Have Two Abstracts Published in the 2022 ASCO Annual Meeting Proceedings
Mar 08, 2022
FirstWord Pharma
OnQuality: OnQuality Pharmaceuticals to Present Preclinical Data for OQL051, a Novel Chemotherapy-Induced Diarrhea Therapeutic, at AACR
Feb 14, 2022
Markets Insider
OnQuality: OnQuality Pharmaceuticals to Present NOVA-II Phase 2 Trial Update and Oncologist Survey Demonstrating Oncodermatology Unmet Need at ASCO GU

Trending Companies